Free Dialysis & Kidney Treatment in Nepal: Eligibility, Sessions & Hospitals

Chronic kidney disease and kidney failure impose one of the heaviest medical costs on Nepali families, because end-stage renal disease requires either regular dialysis or a transplant, both of which run into hundreds of thousands of rupees. To reduce this burden, the Government of Nepal, through the Ministry of Health and Population (MoHP), funds free dialysis and subsidised transplant care under its programme for the medical treatment of deprived citizens, widely known in Nepali as the Bipanna Nagarik (बिपन्न नागरिक) treatment fund.

The programme began providing free lifetime haemodialysis (HD) in 2016, and free kidney transplant support followed in 2017. Kidney and renal failure is one of eight catastrophic disease groups covered by the fund, alongside heart disease, cancer, spinal injury, Parkinson's disease, Alzheimer's disease, sickle cell anaemia and stroke. For most of those other conditions the fund gives a one-time treatment grant of up to Rs 100,000, but for kidney disease the support is more extensive because dialysis is a lifelong, repeating cost.

For a kidney patient the package includes free haemodialysis, free peritoneal dialysis for a defined period, a lump-sum grant toward transplant surgery, and a cash grant plus a monthly allowance for post-transplant medicines. The aim is that a patient who cannot afford treatment can still access dialysis or a transplant at government and empanelled private hospitals without paying the core procedure fee.

Haemodialysis is the most common treatment covered. Most patients with kidney failure need dialysis two to three times a week, with each session lasting roughly three to four hours, which works out to somewhere between about 100 and 156 sessions per year. Under the deprived-citizen programme the government reimburses empanelled centres a fixed amount per session — reported at around Rs 2,500 per session — so the patient is not charged for the dialysis procedure itself.

The scheme is described as lifelong, meaning eligible patients can continue receiving subsidised HD for as long as they need it rather than being cut off after a set number of years. In practice, government guidelines historically framed the coverage in terms of an annual session count (for example, around 104 sessions of haemodialysis in a year, roughly two per week), so the exact number of fully funded sessions in a given year can depend on the current guideline and the hospital's arrangement with the ministry. Patients should confirm the current session entitlement directly with the hospital's social service unit.

It is important to understand what the free service does and does not include. The dialysis session is covered, but associated costs such as certain medicines, the initial vascular access (fistula) surgery, blood transfusions, hospital admission and treatment of complications may still have to be paid by the patient. Reports over the years have also noted that some patients were still charged despite the free-service policy, usually because a centre had reached its funded quota or because reimbursement to the centre was delayed.

Besides haemodialysis, the government also supports peritoneal dialysis (PD), a home-based alternative in which the lining of the abdomen is used to filter the blood. Under continuous ambulatory peritoneal dialysis (CAPD), the programme has provided a monthly quota of free dialysate bags — reported at around 90 bags per month — which is the main recurring consumable cost of PD. Free peritoneal dialysis has generally been offered for a defined coverage period rather than indefinitely.

A kidney transplant is the definitive treatment for end-stage kidney failure and is usually cheaper over the long run than years of dialysis. Under the deprived-citizen fund, the government provides a grant of Rs 200,000 toward the transplant, plus a separate Rs 100,000 cash grant to help buy the anti-rejection (immunosuppressant) medicines that a transplant recipient must take. Older reporting cited roughly equivalent US-dollar figures (around US$1,900 for surgery and US$960 for post-transplant medicine and care), and combined government provision per transplant patient has been reported at up to roughly Rs 550,000 including the monthly allowance.

Because immunosuppressant medicines must be taken for life to prevent the transplanted kidney from being rejected, the fund also gives a monthly allowance of Rs 5,000 to kidney-transplant recipients (as well as cancer and spinal-cord-paralysis patients) to help with the ongoing cost of medication. Even so, patients should budget for expenses beyond these grants, including pre-transplant tissue-typing (HLA) tests, donor work-up, and any medicines not covered by the grant.

The free kidney-treatment programme is targeted at patients who cannot afford care. The core route to eligibility is a recommendation or poverty/deprived-citizen certificate, and additional automatic-eligibility groups have been recognised over time. Broadly, priority goes to low-income (bipanna) patients, senior citizens above the age of 75, and patients with certain infectious conditions such as hepatitis B, hepatitis C and HIV, for whom dialysis carries extra risk and cost.

To access free dialysis a patient typically needs to establish end-stage renal disease through a nephrologist's diagnosis and obtain a deprived-citizen or poverty recommendation, historically issued via the local ward, District Public Health Office or the treating hospital's social service department, along with citizenship documents. The hospital then enrols the patient under the government scheme and claims reimbursement from the ministry, so the patient does not pay the session fee directly.

For a transplant, the patient and a suitable living donor (Nepali law restricts living donation mainly to close relatives, with paired-exchange and deceased-donor pathways added later) go through medical and legal screening at an authorised transplant centre. Because forms, income thresholds and required documents can change with each fiscal-year guideline, the most reliable step is to contact the social service or billing desk of a government or empanelled hospital, or the local health office, before starting treatment.

Free dialysis is delivered through a network of public hospitals, non-governmental dialysis centres and empanelled private hospitals that have signed agreements with the Ministry of Health and Population. Over the years the network has expanded steadily: as of March 2021 Nepal had around 60 haemodialysis centres with roughly 570 machines serving about 3,775 patients, and the government has repeatedly added new empanelled hospitals across all provinces, including private and military hospitals, to widen access.

The largest dedicated dialysis provider is the National Kidney Centre (NKC) in Banasthali, Kathmandu, a non-profit run by the Health Care Foundation-Nepal. It is described as the country's biggest haemodialysis facility, with capacity to serve a few hundred dialysis sessions a day, and it operates units in more than one location in the Kathmandu Valley. NKC participates in the government free-dialysis scheme and provides free dialysis to eligible groups such as patients over 75, supported by ministry funding.

Beyond the National Kidney Centre, free or subsidised dialysis is available at many provincial, zonal and district hospitals and at empanelled private hospitals in cities such as Kathmandu, Pokhara, Bharatpur, Butwal/Bhairahawa, Biratnagar and Nepalgunj. Because the empanelled list is revised as new agreements are signed and existing ones lapse, patients should check the current list of approved centres with the ministry or their nearest large hospital rather than assume any single facility is enrolled.

The flagship public facility for kidney and organ transplantation is the Human Organ Transplant Centre (HOTC), officially the Shahid Dharmabhakta National Transplant Centre, located at Dudhpati, Bhaktapur, in Bagmati Province. Established in 2012 under the Ministry of Health and Population, it is Nepal's dedicated tertiary organ-transplant hospital and the site of the country's first liver transplant and other transplant milestones. It performs kidney and liver transplants (and has expanded toward other organs) and has carried out well over a thousand kidney transplants, with reported success rates around 99 percent for kidneys.

The centre is central to the government's free/subsidised transplant programme, applying the deprived-citizen grants toward surgery and post-transplant medicines so that poorer patients can receive a transplant at little or no direct procedure cost. Even where the grants do not cover the full bill, transplant at HOTC and other approved centres is far cheaper than the same procedure abroad, which was a major reason the government invested in domestic transplant capacity.

Kidney transplantation is also offered at several other hospitals in Nepal, including major teaching and referral hospitals such as Tribhuvan University Teaching Hospital (Institute of Medicine) in Maharajgunj and Bir Hospital in Kathmandu, among others authorised for transplant work. Prospective transplant patients should confirm at the specific centre which government grants apply to their case, what the estimated out-of-pocket cost will be after the subsidy, and what donor and legal documentation is required.

While the headline procedures — the dialysis session and the core transplant surgery — are covered or heavily subsidised, kidney patients and families should plan for related costs that the fund may not fully absorb. For dialysis these can include creation of vascular access (an arteriovenous fistula or catheter), certain medicines such as erythropoietin for anaemia, iron and phosphate binders, laboratory tests, blood transfusions, and treatment of infections or other complications.

For transplantation, expenses beyond the grant can include pre-transplant HLA tissue-typing and cross-match tests, the living donor's evaluation and surgery-related costs, hospital stay beyond the covered package, and any immunosuppressant or other medicines that exceed the Rs 100,000 medicine grant and the Rs 5,000 monthly allowance. Travel and accommodation for patients coming from outside the Kathmandu Valley are also a significant recurring burden for dialysis patients who must attend several sessions a week.

Because rules, grant amounts, session limits and the empanelled-hospital list are set by annual government guidelines and can change, patients should treat the figures here as indicative of the programme's structure rather than a guaranteed current entitlement. The safest approach is to confirm the latest terms with the Ministry of Health and Population, the hospital's social service desk, or the deprived-citizen fund office before and during treatment.